BioXcel Therapeutics, Inc. Increase (Decrease) in Prepaid Expense and Other Assets
BioXcel Therapeutics, Inc. (BTAI) reported Increase (Decrease) in Prepaid Expense and Other Assets of -$639.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets · last filed 2026-08-13
- BioXcel Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-06-30 was -$1.68M.
- BioXcel Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2026-03-31 was $1.04M.
- BioXcel Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-12-31 was $8.35M, a 876.49% increase year-over-year.
- BioXcel Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for the quarter ending 2025-09-30 was $480.00K, a 67.10% decline year-over-year.
- BioXcel Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2025 was $8.16M, a 335.68% increase from fiscal 2024.
- BioXcel Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2024 was $1.87M.
- BioXcel Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2023 was -$2.89M, a 173.96% decline from fiscal 2022.
- BioXcel Therapeutics, Inc. increase (decrease) in prepaid expense and other assets for fiscal 2022 was $3.90M.
| Period end | Increase (Decrease) in Prepaid Expense and Other Assets 3 month | Increase (Decrease) in Prepaid Expense and Other Assets 6 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month | Increase (Decrease) in Prepaid Expense and Other Assets 9 month as first filed | Increase (Decrease) in Prepaid Expense and Other Assets 12 month | Increase (Decrease) in Prepaid Expense and Other Assets 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$639.00K 10-Q · filed 2026-08-13 | $7.71M derived: sum of 3 quarters · filed 2026-08-13 | $8.19M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2026-03-31 | $1.04M 10-Q · filed 2026-05-15 | $9.39M derived: sum of 2 quarters · filed 2026-05-15 | $9.87M derived: sum of 3 quarters · filed 2026-05-15 | $9.80M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-12-31 | $8.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $8.83M derived: sum of 2 quarters · filed 2026-03-27 | $8.76M derived: sum of 3 quarters · filed 2026-08-13 | $8.16M 10-K · filed 2026-03-27 | ||
| 2025-09-30 | $480.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $415.00K derived: sum of 2 quarters · filed 2026-08-13 | -$193.00K 10-Q · filed 2025-11-12 | $662.00K derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-06-30 | -$65.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$673.00K 10-Q · filed 2026-08-13 | $182.00K derived: sum of 3 quarters · filed 2026-08-13 | $1.64M derived: sum of 4 quarters · filed 2026-08-13 | ||
| 2025-03-31 | -$608.00K 10-Q · filed 2026-05-15 | $247.00K derived: sum of 2 quarters · filed 2026-05-15 | $1.71M derived: sum of 3 quarters · filed 2026-05-15 | $2.17M derived: sum of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | $855.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-27 | $2.31M derived: sum of 2 quarters · filed 2026-03-27 | $2.77M derived: sum of 3 quarters · filed 2026-03-27 | $1.87M 10-K · filed 2026-03-27 | ||
| 2024-09-30 | $1.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $1.92M derived: sum of 2 quarters · filed 2025-11-12 | $1.02M 10-Q · filed 2025-11-12 | -$147.00K derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2024-06-30 | $459.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | -$442.00K 10-Q · filed 2025-08-12 | -$1.61M derived: sum of 3 quarters · filed 2025-08-12 | -$3.86M derived: sum of 4 quarters · filed 2025-08-12 | ||
| 2024-03-31 | -$901.00K 10-Q · filed 2025-05-12 | -$2.06M derived: sum of 2 quarters · filed 2025-05-12 | -$4.32M derived: sum of 3 quarters · filed 2025-05-12 | -$5.79M derived: sum of 4 quarters · filed 2025-05-12 | ||
| 2023-12-31 | -$1.16M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | -$3.42M derived: sum of 2 quarters · filed 2025-03-28 | -$4.89M derived: sum of 3 quarters · filed 2025-03-28 | -$2.89M 10-K · filed 2025-03-28 | ||
| 2023-09-30 | -$2.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | -$3.73M derived: sum of 2 quarters · filed 2024-11-14 | -$1.72M 10-Q · filed 2024-11-14 | -$2.75M derived: sum of 4 quarters · filed 2024-11-14 | ||
| 2023-06-30 | -$1.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $527.00K 10-Q · filed 2024-08-06 | -$502.00K derived: sum of 3 quarters · filed 2024-08-06 | -$2.64M derived: sum of 4 quarters · filed 2024-08-06 | ||
| 2023-03-31 | $2.01M 10-Q · filed 2024-05-09 | $977.00K derived: sum of 2 quarters · filed 2024-05-09 | -$1.16M derived: sum of 3 quarters · filed 2024-05-09 | $2.43M derived: sum of 4 quarters · filed 2024-05-09 | ||
| 2022-12-31 | -$1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | -$3.17M derived: sum of 2 quarters · filed 2024-03-22 | $425.00K derived: sum of 3 quarters · filed 2024-03-22 | $3.90M 10-K · filed 2024-03-22 | ||
| 2022-09-30 | -$2.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $1.45M derived: sum of 2 quarters · filed 2023-11-14 | $4.93M 10-Q · filed 2023-11-14 | $3.09M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $3.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $7.07M 10-Q · filed 2023-08-14 | $5.23M derived: sum of 3 quarters · filed 2023-08-14 | $5.91M derived: sum of 4 quarters · filed 2023-08-14 | ||
| 2022-03-31 | $3.48M 10-Q · filed 2023-05-09 | $1.64M derived: sum of 2 quarters · filed 2023-05-09 | $2.31M derived: sum of 3 quarters · filed 2023-05-09 | $4.08M derived: sum of 4 quarters · filed 2023-05-09 | ||
| 2021-12-31 | -$1.84M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | -$1.17M derived: sum of 2 quarters · filed 2023-03-16 | $600.00K derived: sum of 3 quarters · filed 2023-03-16 | -$103.00K 10-K · filed 2023-03-16 | ||
| 2021-09-30 | $675.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $2.44M derived: sum of 2 quarters · filed 2022-11-14 | $1.74M 10-Q · filed 2022-11-14 | $2.98M derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $1.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.06M 10-Q · filed 2022-08-11 | $2.31M derived: sum of 3 quarters · filed 2022-08-11 | $2.23M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | -$703.00K 10-Q · filed 2022-05-09 | $539.00K derived: sum of 2 quarters · filed 2022-05-09 | $461.00K derived: sum of 3 quarters · filed 2022-05-09 | -$240.00K derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-12-31 | $1.24M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $1.16M derived: sum of 2 quarters · filed 2022-03-11 | $463.00K derived: sum of 3 quarters · filed 2022-03-11 | $2.30M 10-K · filed 2022-03-11 | $2.01M 10-K · filed 2021-03-12 | |
| 2020-09-30 | -$78.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | -$779.00K derived: sum of 2 quarters · filed 2021-11-10 | $1.06M 10-Q · filed 2021-11-10 | $846.00K 10-Q · filed 2020-11-12 | $1.63M derived: sum of 4 quarters · filed 2021-11-10 | |
| 2020-06-30 | -$701.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $1.14M 10-Q · filed 2021-08-10 | $1.71M derived: sum of 3 quarters · filed 2021-08-10 | $1.32M derived: sum of 4 quarters · filed 2021-08-10 | ||
| 2020-03-31 | $1.84M 10-Q · filed 2021-05-10 | $2.41M derived: sum of 2 quarters · filed 2021-05-10 | $2.02M derived: sum of 3 quarters · filed 2021-05-10 | $1.74M derived: sum of 4 quarters · filed 2021-05-10 | ||
| 2019-12-31 | $572.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $181.00K derived: sum of 2 quarters · filed 2021-03-12 | -$102.00K derived: sum of 3 quarters · filed 2021-03-12 | $1.19M 10-K · filed 2021-03-12 | ||
| 2019-09-30 | -$391.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | -$674.00K derived: sum of 2 quarters · filed 2020-11-12 | $618.00K 10-Q · filed 2020-11-12 | $642.00K derived: sum of 4 quarters · filed 2020-11-12 | ||
| 2019-06-30 | -$283.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $1.01M 10-Q · filed 2020-08-14 | $1.03M derived: sum of 3 quarters · filed 2020-08-14 | $882.00K derived: sum of 4 quarters · filed 2020-08-14 | ||
| 2019-03-31 | $1.29M 10-Q · filed 2020-05-12 | $1.32M derived: sum of 2 quarters · filed 2020-05-12 | $1.17M derived: sum of 3 quarters · filed 2020-05-12 | $1.03M derived: sum of 4 quarters · filed 2020-05-12 | ||
| 2018-12-31 | $24.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-09 | -$127.00K derived: sum of 2 quarters · filed 2020-03-09 | -$266.00K derived: sum of 3 quarters · filed 2020-03-09 | $539.00K 10-K · filed 2020-03-09 | ||
| 2018-09-30 | -$151.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$290.00K derived: sum of 2 quarters · filed 2019-11-14 | $515.00K 10-Q · filed 2019-11-14 | $507.00K derived: sum of 4 quarters · filed 2019-11-14 | ||
| 2018-06-30 | -$139.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $666.00K 10-Q · filed 2019-08-06 | $658.00K derived: sum of 3 quarters · filed 2019-08-06 | |||
| 2018-03-31 | $805.00K 10-Q · filed 2019-05-07 | $797.00K derived: sum of 2 quarters · filed 2019-05-07 | ||||
| 2017-12-31 | -$8.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $1.00K 10-K · filed 2019-03-12 | ||||
| 2017-09-30 | $9.00K 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |